Literature DB >> 24422069

Oral recombinant PTH shows promise but is not as good as teriparatide.

.   

Abstract

Entities:  

Year:  2013        PMID： 24422069      PMCID： PMC3722756          DOI： 10.1038/bonekey.2013.55

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN： 2047-6396


× No keyword cloud information.
  1 in total

1.  Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH(2)] in postmenopausal women with osteoporosis.

Authors:  K Henriksen; J R Andersen; B J Riis; N Mehta; R Tavakkol; P Alexandersen; I Byrjalsen; I Valter; B S Nedergaard; C S Teglbjaerg; W Stern; A Sturmer; S Mitta; A J Nino; L A Fitzpatrick; C Christiansen; M A Karsdal
Journal:  Bone       Date:  2012-12-09       Impact factor: 4.398
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.